Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Tongjitang Completes $20 Million Stock Buyback

publication date: Oct 13, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Tongjitang Chinese Medicines Company announced it has bought back 19.3 million shares of its stock from four institutional funds. The buyback represents 15% of Tongjitang’s outstanding shares, reducing the count of outstanding shares from 128.2 million to 108.9 million. The company said the average price paid was $4.10 per ADS (each ADS is equivalent to four ordinary shares). More details...

Stock Symbol: (NYSE: TCM)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...